Cited 0 times in
Single-center real-world treatment outcomes of ablative fractional laser-assisted photodynamic therapy for actinic keratosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, DC | - |
dc.contributor.author | Han, HJ | - |
dc.contributor.author | Kim, SI | - |
dc.contributor.author | Park, B | - |
dc.contributor.author | Kim, YC | - |
dc.date.accessioned | 2023-05-23T04:04:18Z | - |
dc.date.available | 2023-05-23T04:04:18Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 0905-4383 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/25536 | - |
dc.description.abstract | Background: Among various treatment modalities of actinic keratosis (AK), ablative fractional laser-assisted photodynamic therapy (fractional PDT) has shown higher efficacy despite shorter incubation time. However, there are lack of real-world studies on the therapeutic response of ablative PDT for AK and the factors that can predict the therapeutic response. Purpose: The aim of this study was to analyze the association between clinical characteristics and treatment outcomes of fractional PDT. Methods: One hundred fifty-six patients who were histologically diagnosed with AK and treated with fractional PDT were retrospectively reviewed. The Kruskal–Wallis test was used to compare treatment session differences according to grades. Results: In multivariate analysis, the grade 2 category tended to be more clinically nonresponders than the grade 1 (OR, 5.17; 95% CI, 1.011–26.439; p =.048) and the group treated four or more times with ablative fractional laser-assisted PDT were more likely to show no response compared with the single treatment session group (OR, 8.78; 95% CI, 1.355–56.874; p =.023). Treatment sessions were significantly lower in grade 1 (1.72 ± 0.63, mean ± SD) when compared to grades 2 and 3, respectively (2.17 ± 0.76; 2.60 ± 1.60, mean ± SD). Recurrence was highest in grade 2, and most of them occurred after 1 year. Conclusion: On average, two treatment sessions are sufficient for AK lesions, but the thicker the lesion, the more treatment sessions may be required. Although there are relatively smaller number of grade 3 patients were included, recurrence was more frequent in higher grade of AK category, which needs special attention to thicker lesions. | - |
dc.language.iso | en | - |
dc.subject.MESH | Aminolevulinic Acid | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Keratosis, Actinic | - |
dc.subject.MESH | Lasers | - |
dc.subject.MESH | Photochemotherapy | - |
dc.subject.MESH | Photosensitizing Agents | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Single-center real-world treatment outcomes of ablative fractional laser-assisted photodynamic therapy for actinic keratosis | - |
dc.type | Article | - |
dc.identifier.pmid | 36579473 | - |
dc.subject.keyword | actinic keratosis | - |
dc.subject.keyword | fractional laser | - |
dc.subject.keyword | photodynamic therapy | - |
dc.subject.keyword | treatment outcome | - |
dc.contributor.affiliatedAuthor | Park, B | - |
dc.contributor.affiliatedAuthor | Kim, YC | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1111/phpp.12858 | - |
dc.citation.title | Photodermatology, photoimmunology & photomedicine | - |
dc.citation.volume | 39 | - |
dc.citation.number | 2 | - |
dc.citation.date | 2023 | - |
dc.citation.startPage | 116 | - |
dc.citation.endPage | 121 | - |
dc.identifier.bibliographicCitation | Photodermatology, photoimmunology & photomedicine, 39(2). : 116-121, 2023 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1600-0781 | - |
dc.relation.journalid | J009054383 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.